Search

Company
Science
Clinical Candidates
Investor & Media

Company
Science
Clinical Candidates
Investor & Media

ASX: RCE

$0.0

Company
Science
Clinical Candidates
Investor & Media

Company
Science
Clinical Candidates
Investor & Media

ASX: RCE

$0.0

Company
Science
Clinical Candidates
Investor & Media

Company
Science
Clinical Candidates
Investor & Media

ASX: RCE

$0.0

Search

RCE.AX – Global IP protection now complete (050824)

RCE.AX – Global IP protection now complete (050824)

Quick Links

Company
Product Candidates
Investors & Media
Contact Us
Privacy Policy
Disclaimer

Company
Product Candidates
Investors & Media
Contact Us
Privacy Policy
Disclaimer

About Us

Recce Pharmaceuticals Ltd (ASX:RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat of antibiotic-resistant superbugs.

Stay up to date

Receive news and information direct to your inbox.

Name

Email

Twitter Linkedin-in Youtube Instagram

© 2026 Recce Pharmaceuticals